CBRE has announced the $16.25 million (5.9% cap rate) sale of Creek Medical Buildings, a three-building, 43,374-square-foot medical office property located at 37, 39 and 41 Creek Road in Irvine, California.
CBRE National Office Partners’ Anthony DeLorenzo, along with Sammy Cemo, Bryan Johnson and Harry Su of Private Capital Partners, represented the seller in the transaction.
“Creek Medical Buildings offered a compelling opportunity to acquire a fully leased medical office asset in one of Orange County’s most desirable healthcare hubs,” said DeLorenzo, vice chairman at CBRE. “The property’s strong tenant mix, below-market rents, and prime location in Irvine position it well for long-term value creation. We’re proud to have played a role in this successful transaction.”
Built in 1986, the property is fully occupied. The three buildings are strategically positioned within Irvine’s highly sought-after healthcare corridor in the Woodbridge neighborhood of Irvine. The property benefits from exceptional connectivity, offering seamless access to major transportation arteries, a robust and affluent demographic, and a concentration of leading medical providers.
About CBRE Group, Inc.
CBRE Group, Inc. (NYSE:CBRE), a Fortune 500 and S&P 500 company headquartered in Dallas, is the world’s largest commercial real estate services and investment firm (based on 2024 revenue). The company has more than 140,000 employees (including Turner & Townsend employees) serving clients in more than 100 countries. CBRE serves clients through four business segments: Advisory (leasing, sales, debt origination, mortgage servicing, valuations); Building Operations & Experience (facilities management, property management, flex space & experience); Project Management (program management, project management, cost consulting); Real Estate Investments (investment management, development). Please visit our website at www.cbre.com.
The full content of this article is only available to paid subscribers. If you are an active subscriber, please log in. To subscribe, please click here: SUBSCRIBE
